Recent Chronic Lymphocytic Leukemia News

Many Patients with “Chemo Brain” Recover within Five Years (May 23, 2011)

A study of “chemo brain”—the foggy thinking and forgetfulness that patients may experience after chemotherapy—suggests that the condition improves substantially over time for a majority of patients.... Continue Reading

Fludara plus Rituxan Extends Survival in CLL (April 6, 2010)

Patients with untreated chronic lymphocytic leukemia experienced prolonged survival when treated with Fludara® (fludarabine) plus Rituxan® (rituximab) (delivered either concurrently or sequentially),... Continue Reading

Rituxan Approved for Chronic Lymphocytic Leukemia (February 24, 2010)

The U.S. Food and Drug Administration (FDA) has expanded the approval of Rituxan® (rituximab) to include the treatment of certain patients with chronic lymphocytic leukemia. Chronic lymphocytic leukemia... Continue Reading

Arzerra™ Approved for Refractory Chronic Lymphocytic Leukemia (October 28, 2009)

The targeted therapy Arzerra™ (ofatumumab) has been granted accelerated approval by the U.S. Food and Drug Administration for treatment of patients with chronic lymphocytic leukemia (CLL) that is refractory... Continue Reading

Abnormal Cells Identified in Blood Years Before Diagnosis of CLL (March 9, 2009)

According to the results of a study published in the New England Journal of Medicine, chronic lymphocytic leukemia (CLL) appears to be preceded by a condition known as monoclonal B-cell lymphocytosis (MBL). Chronic... Continue Reading